Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies
Open Access
- 26 July 2016
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 30464
Abstract
Evidence suggests that plasminogen activator inhibitor-1 (PAI-1) is a stress-related factor, and serum PAI-1 levels are increased in patients with major depressive disorders (MDD). Herein, we analysed PAI-1 protein levels in the brain, cerebrospinal fluid (CSF) and serum of rodents exposed to chronic unpredictable mild stress or treated with escitalopram. In addition, we examined PAI-1 concentrations in serum obtained from 17 drug-free depressed patients before and after escitalopram treatment. We found that PAI-1 expression was increased in area 1 of the cingulate cortex and prelimbic cortex of the medial prefrontal cortex as well as in the hippocampal cornu ammonis 3 and dentate gyrus in stressed rats. A downregulation of PAI-1 following chronic escitalopram treatment was also found. PAI-1 levels were higher in the CSF and serum in stressed rats than in controls, although the difference did not reach statistical significance in the serum. Escitalopram treatment significantly decreased PAI-1 levels in the serum, but not in the CSF. MDD patients had significantly greater serum PAI-1 concentrations than controls. Our results suggest that PAI-1 is implicated in the pathophysiology of depression.Keywords
This publication has 38 references indexed in Scilit:
- Review: the role of inflammation in depression.2013
- A model of amygdala–hippocampal–prefrontal interaction in fear conditioning and extinction in animalsBrain and Cognition, 2013
- Hippocampus-specific deletion of tissue plasminogen activator “tPA” in adult mice impairs depression- and anxiety-like behaviorsEuropean Neuropsychopharmacology, 2012
- Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioningPsychoneuroendocrinology, 2012
- Neural circuits underlying the pathophysiology of mood disordersTrends in Cognitive Sciences, 2012
- Modeling Depression in Animal Models2011
- Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment responsePharmacogenetics and Genomics, 2008
- Interaction between BDNF and Serotonin: Role in Mood DisordersNeuropsychopharmacology, 2007
- Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular riskMetabolism, 2005
- Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissuesNeuroscience Letters, 2001